Cargando…
Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL; α/β T-cell subtype) is a distinct variantof cutaneous T-cell lymphomas, which presents as inflammatory subcutaneous nodules. A 17-year-old male presented with recurrent fever with concomitant facial swelling, pedal edema, hepatosplenomegaly, and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134172/ https://www.ncbi.nlm.nih.gov/pubmed/27990393 http://dx.doi.org/10.4103/2229-5178.193909 |
_version_ | 1782471415812849664 |
---|---|
author | Asati, Dinesh P. Ingle, Vaibhav Joshi, Deepti Tiwari, Anurag |
author_facet | Asati, Dinesh P. Ingle, Vaibhav Joshi, Deepti Tiwari, Anurag |
author_sort | Asati, Dinesh P. |
collection | PubMed |
description | Subcutaneous panniculitis-like T-cell lymphoma (SPTCL; α/β T-cell subtype) is a distinct variantof cutaneous T-cell lymphomas, which presents as inflammatory subcutaneous nodules. A 17-year-old male presented with recurrent fever with concomitant facial swelling, pedal edema, hepatosplenomegaly, and mildly tender subcutaneous plaques in generalized distribution along with patches of scarring alopecia on scalp. There were features of macrophage activation syndrome in the form of hemophagocytosis in the bone marrow, pancytopenia, high serum lactate dehydrogenase levels, low fibrinogen clotting activity, prolonged activated prothrombine time (aPTT), increased serum ferritin, hypoalbuminemia, and hypertriglyceridemia. Histopathology showed lobular panniculitis-like infiltration by atypical lymphocytes rimming the adipocytes. Immunohistochemistry revealed positive CD3 and CD8 markers, whereas CD4, CD56, and CD20 were negative, consistent with the diagnosis of α/β type of SPTCL. Treatment with oral prednisolone (1mg/kg/day) and cyclosporine (2mg/kg/day; 100 mg) led to rapid subsidence of fever, plaques, and abnormal hematological parameters within a few weeks. |
format | Online Article Text |
id | pubmed-5134172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-51341722016-12-16 Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone Asati, Dinesh P. Ingle, Vaibhav Joshi, Deepti Tiwari, Anurag Indian Dermatol Online J Case Report Subcutaneous panniculitis-like T-cell lymphoma (SPTCL; α/β T-cell subtype) is a distinct variantof cutaneous T-cell lymphomas, which presents as inflammatory subcutaneous nodules. A 17-year-old male presented with recurrent fever with concomitant facial swelling, pedal edema, hepatosplenomegaly, and mildly tender subcutaneous plaques in generalized distribution along with patches of scarring alopecia on scalp. There were features of macrophage activation syndrome in the form of hemophagocytosis in the bone marrow, pancytopenia, high serum lactate dehydrogenase levels, low fibrinogen clotting activity, prolonged activated prothrombine time (aPTT), increased serum ferritin, hypoalbuminemia, and hypertriglyceridemia. Histopathology showed lobular panniculitis-like infiltration by atypical lymphocytes rimming the adipocytes. Immunohistochemistry revealed positive CD3 and CD8 markers, whereas CD4, CD56, and CD20 were negative, consistent with the diagnosis of α/β type of SPTCL. Treatment with oral prednisolone (1mg/kg/day) and cyclosporine (2mg/kg/day; 100 mg) led to rapid subsidence of fever, plaques, and abnormal hematological parameters within a few weeks. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC5134172/ /pubmed/27990393 http://dx.doi.org/10.4103/2229-5178.193909 Text en Copyright: © Indian Dermatology Online Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Asati, Dinesh P. Ingle, Vaibhav Joshi, Deepti Tiwari, Anurag Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone |
title | Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone |
title_full | Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone |
title_fullStr | Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone |
title_full_unstemmed | Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone |
title_short | Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone |
title_sort | subcutaneous panniculitis-like t-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134172/ https://www.ncbi.nlm.nih.gov/pubmed/27990393 http://dx.doi.org/10.4103/2229-5178.193909 |
work_keys_str_mv | AT asatidineshp subcutaneouspanniculitisliketcelllymphomawithmacrophageactivationsyndrometreatedbycyclosporineandprednisolone AT inglevaibhav subcutaneouspanniculitisliketcelllymphomawithmacrophageactivationsyndrometreatedbycyclosporineandprednisolone AT joshideepti subcutaneouspanniculitisliketcelllymphomawithmacrophageactivationsyndrometreatedbycyclosporineandprednisolone AT tiwarianurag subcutaneouspanniculitisliketcelllymphomawithmacrophageactivationsyndrometreatedbycyclosporineandprednisolone |